Literature DB >> 22259659

Metabolic syndrome and myocardial contractile reserve.

Seong Hwan Kim1.   

Abstract

Entities:  

Year:  2011        PMID: 22259659      PMCID: PMC3259540          DOI: 10.4250/jcu.2011.19.4.174

Source DB:  PubMed          Journal:  J Cardiovasc Ultrasound        ISSN: 1975-4612


× No keyword cloud information.
REFER TO THE PAGE 176-182 Metabolic syndrome (MetS) is a clustering of cardiovascular risk factors including hyperglycemia, dyslipidemia, and hypertension, which have been shown to increase cardiovascular (CV) morbidity and mortality.1)2) In addition, it is well known that the association between the presence of MetS and adverse CV outcomes is independent of diabetes mellitus (DM) and arterial hypertension.3)4) Since the MetS is a strong predictor of future CV events, the changes of left ventricular (LV) structure and function in patients with MetS are considered one of mechanisms explaining the link between the MetS and CV morbidity and mortality. The previous studies have already reported the LV geometry and function by demonstrating increased LV mass and subclinical LV systolic and/or diastolic dysfunctionis impaired in the MetS patients.5-7) However, the most studies were conducted in the resting state, not during exercise. Considering that most patients with type 2 DM and/or hypertension have symptoms during exercise, the study by Ha et al.8) suggests that the patients with MetS might also have decreased LV functional reserve during dynamic exercise. A total of 112 hypertensive patients complaining of exertional dyspnea were included and divided into two groups according to the existence of MetS. Exercise stress echocardiography using supine bicycle was performed and a variety of Doppler parameters were measured at baseline, at each stage of exercise, and during recovery. There was a significant difference in E/E' parameter, that is an index of LV filling pressure, in MetS patients at resting state. The increased E/E' value was maintained during dynamic exercise test, which is similar to the result of a prior study.9) A unique result to this study is that LV longitudinal functional reserve, defined as the change in tissue Doppler imaging (TDI), S' (longitudinal tissue velocity) from baseline to peak exercise was significantly lower in MetS patients even though there was no significant difference in baseline TDI S' velocity between the two. After adjusting for known CV risk factors, an independent relationship between the presence of MetS and LV systolic functional reserve was observed. The recent use of TDI, strain, and strain rate at resting state allows detecting earlier subclinical dysfunction and providing essential mechanisms in understanding the development of heart failure. In addition, TDI parameters such as S', E', A', and E/E' have been known to have independent prognostic values in various cardiac diseases,10) even in low risk population.11) However, there is a study showing that resting LV TDI parameter did not add any incremental prognostic impact over the clinical data in patients with type 2 DM.12) Thus, even though exercise capacity is already recognized as a significant predictor of CV diseases, the LV TDI measurements acquired by stress echocardiography seem to be more reliable and stronger in detecting the presence of subclinical CV disease13) and predicting clinical outcome,12) compared with resting TDI values. Nevertheless, measuring Doppler parameters including TDI during exercise stress echocardiography for the evaluation of longitudinal diastolic functional reserve is still challenging, especially at peak stress, because the mitral velocities summate as the heart rate increases. In this study, no differences in longitudinal diastolic functional reserve may be due to these limitations in addition to a small sample size. Although the exact mechanism related to abnormal contractile reserve in patients with MetS is still unknown, it seems that multiple factors including sympathetic nervous system, renin-angiotensin-aldosterone system, myocardial metabolism, and coronary flow reserve contribute to subclinical dysfunction of longitudinal myocardial contraction during exercise. In summary, MetS is associated with LV systolic and diastolic dysfunction at resting state and decreased LV longitudinal contractile reserve during exercise despite of similar values at baseline examination. Although larger studies to confirm the results of this study are needed, the assessment of longitudinal functional reserve in MetS patients, using exercise stress echocardiography, is helpful for earlier identification of subclinical dysfunction and more aggressive treatment strategies to prevent a progression to overt heart failure.
  13 in total

1.  Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome.

Authors:  Chiew Y Wong; Trisha O'Moore-Sullivan; Zhi Y Fang; Brian Haluska; Rodel Leano; Thomas H Marwick
Journal:  Am J Cardiol       Date:  2005-10-26       Impact factor: 2.778

2.  Abnormal left ventricular longitudinal functional reserve assessed by exercise pulsed wave tissue Doppler imaging in patients with subclinical hypothyroidism.

Authors:  Mustafa Akcakoyun; Hasan Kaya; Ramazan Kargin; Selcuk Pala; Yunus Emiroglu; Ozlem Esen; Hekim Karapinar; Zekeriya Kaya; Ali Metin Esen
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

3.  Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value.

Authors:  Mei Wang; Gabriel W K Yip; Angela Y M Wang; Yan Zhang; Pik Yuk Ho; Mui Kiu Tse; Peggo K W Lam; John E Sanderson
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

4.  Impact of left ventricular longitudinal diastolic functional reserve on clinical outcome in patients with type 2 diabetes mellitus.

Authors:  Sung-Ai Kim; Chi-Young Shim; Jin-Mi Kim; Hyun-Jin Lee; Dong-Hoon Choi; Eui-Young Choi; Yangsoo Jang; Namsik Chung; Jong-Won Ha
Journal:  Heart       Date:  2011-06-07       Impact factor: 5.994

5.  Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass.

Authors:  Lisa de las Fuentes; Angela L Brown; Santhosh J Mathews; Alan D Waggoner; Pablo F Soto; Robert J Gropler; Víctor G Dávila-Román
Journal:  Eur Heart J       Date:  2007-02-20       Impact factor: 29.983

6.  Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Cecil M Burchfiel; Thomas N Skelton; Michael E Andrew; Robert J Garrison; Donna K Arnett; Daniel W Jones; Herman A Taylor
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

7.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

8.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.

Authors:  Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Sten Madsbad
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

9.  Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Lyle G Best; Elisa T Lee; James M Galloway; Helaine E Resnick
Journal:  Diabetes Care       Date:  2007-04-17       Impact factor: 19.112

10.  The Effect of Metabolic Syndrome on Myocardial Contractile Reserve during Exercise in Non-Diabetic Hypertensive Subjects.

Authors:  Tae Hoon Ha; Hye-Sun Seo; Woo Jin Choo; Jaehuk Choi; Jon Suh; Youn-Haeng Cho; Nae-Hee Lee
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27
View more
  1 in total

1.  Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome.

Authors:  Vera Celic; Anka Majstorovic; Biljana Pencic-Popovic; Aleksandra Sljivic; Natalia Lopez-Andres; Ignacio Roy; Elena Escribano; Maite Beunza; Amaia Melero; Federico Floridi; Laura Magrini; Rossella Marino; Gerardo Salerno; Patrizia Cardelli; Salvatore Di Somma
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.